An Open Label, Phase IV, Multi-Centric, Prospective, Single Arm Study to Assess the Safety and Efficacy of Fluca Eye Drops Containing Sodium Cromoglycate (20 mg/ml) and Fluorometholone (1 mg/ml) in Subjects with Chronic Allergic Conjunctivitis and Hay Fever

drug protocol number
FLUCA001
drug sponsor
Jamjoom Pharmaceuticals
drug study
FLUCA
drug trial site
King Khalid University Hospital (Riyadh)
drug status
Completed
drug phase